Publication | Closed Access
A Phase I/II Randomized Open-Label Multicenter Trial of Efalizumab, a Humanized Anti-CD11a, Anti-LFA-1 in Renal Transplantation
165
Citations
37
References
2007
Year
UrologyTransplantationKidney TransplantKidney TransplantationTransplantation MedicineImmunologyClinical TrialsGraft RejectionRenal TransplantationImmunotherapyMedicineCell TransplantationNephrologyHumanized Anti-cd11a
| Year | Citations | |
|---|---|---|
Page 1
Page 1